Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 2, 2006

View Archived Issues

TMC-114 plus ritonavir safe in HIV-hepatitis coinfection

R-1626 shows promise in hepatitis C

AEE-788 investigated in hepatocellular carcinoma

Pentoxifylline assessed in clinical trials in liver diseases

Platrol, a safe sustained release antiplatelet drug

CTT Cancer Targeting Technologies and Karyon to merge

Crofelemer studied for D-IBS in new phase IIb trial

Stelic discovers new treatment approach for acute liver failure

Acenta and NCI collaborate on novel Akt inhibitors for cancer

Adherex and SIOPEL sign in support of phase III oroprotectant study of STS

Novel antiinfective agents disclosed in recent patent literature

New therapeutic agents for gastrointestinal disorders disclosed in recent patents

Novel agents for fibrotic disorders patented

Novel CYP2A inhibitors for smoking cessation patented by InflaZyme

Novel cannabinoid agonists reported by Adolor

Satori Pharmaceuticals' SPI-014 exhibits Abeta42-lowering activity in vitro and in vivo

Secretin studied for utility in functional MRI of the pancreas

Ribose shows potential in CHF patients

Genasense: NDA review extended in CLL, pivotal enrollment completed in AML

MB-07811 studied in phase I for management of hyperlipidemia

NG2-73 begins phase II study in chronic insomnia patients

BIW-8405 begins phase I trial for asthma

Albany Molecular Research advances oncology candidate towards IND filing

Merck & Co. to acquire Sirna Therapeutics

RP-101 cleared to begin phase II study in pancreatic cancer

Advexin to be filed under EMEA Exceptional Circumstances rules

Tesofensine cleared for phase I/II metabolic study

Phase II findings for U-101 in chronic pelvic pain of bladder origin

Emerging natural products for the treatment of neurological disorders: Part II

Emisphere's oral insulin shows efficacy in type 2 diabetes patients

FDA approval for Polyphenon E Ointment

Approvable letter for Zenvia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 16, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...